Quick Answer
Korro Bio, Inc. reported Total Revenue of $6.39 million for fiscal year 2025.
Korro Bio, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $6.39M | +181.5% |
| 2024 | $2.27M | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | -100.0% |
| 2021 | $14.07M | -62.0% |
| 2020 | $36.98M | +27.8% |
| 2019 | $28.95M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.09M | — | -25.3% |
| June 30, 2025 | $1.46M | — | -42.7% |
| March 31, 2025 | $2.55M | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2022 | $0.00 | — | — |
| June 30, 2022 | $0.00 | -100.0% | — |
- Korro Bio, Inc. showed an increase of +181.5% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Korro Bio, Inc.’s total revenue has declined by 77.9% (from $28.95 million to $6.39 million).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: